A detailed history of Exome Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Exome Asset Management LLC holds 8,247 shares of LLY stock, worth $6.96 Million. This represents 4.78% of its overall portfolio holdings.

Number of Shares
8,247
Previous 10,447 21.06%
Holding current value
$6.96 Million
Previous $9.26 Billion 31.21%
% of portfolio
4.78%
Previous 6.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$727.2 - $932.06 $1.6 Million - $2.05 Million
-2,200 Reduced 21.06%
8,247 $6.37 Billion
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $576,788 - $717,134
747 Added 7.7%
10,447 $9.26 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $5.09 Million - $6.01 Million
9,700 New
9,700 $5.65 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $802B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.